Biomanufacturing (BioMAN) Program

The Biomanufacturing program at MIT (BioMAN) connects industry, academia, and government to identify challenges and best practices in biologics manufacturing. As a neutral third party, MIT provides a pre-competitive environment where stake-holders can work together to develop improvements in biomanufacturing. BioMAN projects leverage the strengths of MIT faculty in the schools of Science, Engineering, and Management.

Provide a safe haven for collaborative, pre-competitive research among industry, academia, and government.

Provide a forum for companies to benchmark and identify best industry practices on the manufacture of existing and emerging therapies and be exposed to the novel technologies and capabilities of MIT most relevant to the biotherapeutics industry.

Increase awareness at MIT of unmet needs and opportunities in bioprocessing that map to faculty expertise.

Facilitate cross- and interdisciplinary research leveraging MIT’s world class expertise in engineering, science, economics, and business strategy to address challenges to the manufacturing and delivery of biologics.

Create impactful educational experiences to expand the reach of biomanufacturing education and to better connect theoretical concepts to real-world applications.

BioMAN seeks to develop new knowledge, science, technologies and strategies that advance the manufacture and global delivery of high quality biopharmaceuticals by hosting workshops and conducting projects related to the BioMAN Focus Areas.
For more information or to join BioMAN, please contact:

Stacy L. Springs, PhD
Executive Director, Biomanufacturing Program (BioMAN)
Executive Director, Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB)
Phone: 617-253-3084